Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33213

1.

MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.

Yuan Y, Niu F, Nolte IM, Koerts J, de Jong D, Rutgers B, Osinga J, Azkanaz M, Terpstra M, Bystrykh L, Diepstra A, Visser L, Dzikiewicz-Krawczyk A, Kok K, Kluiver J, van den Berg A.

Cell Physiol Biochem. 2018;49(1):144-159. doi: 10.1159/000492850. Epub 2018 Sep 5.

2.

[Therapeutic approach against malignant Hodgkin's lymphoma during pregnancy: about a case and literature review].

Alami Z, Bouhafa T, Elmazghi A, Hassouni K.

Pan Afr Med J. 2018 May 9;30:20. doi: 10.11604/pamj.2018.30.20.14662. eCollection 2018. Review. French.

3.

[Hodgkin lymphoma and target definition guidelines].

Peignaux K, Gonzague-Casabianca L.

Cancer Radiother. 2018 Sep;22(5):401-403. doi: 10.1016/j.canrad.2018.07.010. Epub 2018 Aug 6. Review. French.

PMID:
30093312
4.

[Radiation therapy planning for Hodgkin lymphoma: Focus on intensity-modulated radiotherapy, gating, protons. Which techniques to best deliver radiation?]

Boros A, Ribrag V, Deutsch É, Chargari C, Izar F.

Cancer Radiother. 2018 Sep;22(5):404-410. doi: 10.1016/j.canrad.2018.07.007. Epub 2018 Jul 31. Review. French.

PMID:
30076071
5.

Evidence of EBV infection in lymphomas diagnosed in Lusaka, Zambia.

Kafita D, Kaile T, Malyangu E, Tembo R, Zulu E, Chisanga C, Kalonda A, Samutela M, Polepole P, Kwenda G.

Pan Afr Med J. 2018 Mar 28;29:181. doi: 10.11604/pamj.2018.29.181.11847. eCollection 2018.

6.

Multimodality imaging using PET/CT (18F)-fluorodeoxyglucose for radiotherapy field delineation of localized Hodgkin lymphoma.

Édeline V, Remouchamps V, Isnardi V, Vander Borght T.

Cancer Radiother. 2018 Sep;22(5):384-392. doi: 10.1016/j.canrad.2018.07.008. Epub 2018 Jul 25. Review.

PMID:
30055933
7.

Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP).

Pavone V, Mele A, Carlino D, Specchia G, Gaudio F, Perrone T, Mazza P, Palazzo G, Guarini A, Loseto G, Eleonora P, Cascavilla N, Scalzulli P, Melpignano A, Quintana G, Di Renzo N, Tarantini G, Capalbo S.

Ann Hematol. 2018 Oct;97(10):1817-1824. doi: 10.1007/s00277-018-3379-5. Epub 2018 Jul 27.

PMID:
30054707
8.

Role of FDG PET-CT in the treatment management of Hodgkin lymphoma.

Berriolo-Riedinger A, Becker S, Casasnovas O, Vander Borght T, Édeline V.

Cancer Radiother. 2018 Sep;22(5):393-400. doi: 10.1016/j.canrad.2018.06.001. Epub 2018 Jul 20. Review.

PMID:
30033076
9.

Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).

Goldkuhle M, Dimaki M, Gartlehner G, Monsef I, Dahm P, Glossmann JP, Engert A, von Tresckow B, Skoetz N.

Cochrane Database Syst Rev. 2018 Jul 12;7:CD012556. doi: 10.1002/14651858.CD012556.pub2. Review.

PMID:
30001476
10.

[Toxic epidermal necrolysis during a hemophagocytic syndrome secondary to Hodgkin lymphoma. Report of one case].

Peña C, Voisin J, González JT, Villegas P.

Rev Med Chil. 2018 Apr;146(4):523-527. doi: 10.4067/s0034-98872018000400523. Spanish.

11.

Complete Local and Abscopal Responses from a Combination of Radiation and Nivolumab in Refractory Hodgkin's Lymphoma.

Qin Q, Nan X, Miller T, Fisher R, Teh B, Pandita S, Farach AM, Pingali SR, Pandita RK, Butler EB, Pandita TK, Iyer SP.

Radiat Res. 2018 Sep;190(3):322-329. doi: 10.1667/RR15048.1. Epub 2018 Jun 27.

PMID:
29949442
12.

A Mediastinal Mass in a Young Man.

Jain S, Gupta A, Nagalla S.

JAMA. 2018 Jun 19;319(23):2432-2433. doi: 10.1001/jama.2018.7107. No abstract available.

PMID:
29922807
13.

Osteonecrosis in Hodgkin lymphoma treated by BEACOPP.

Albano D, Patti C, Midiri M, Galia M.

Intern Med J. 2018 Jun;48(6):747-748. doi: 10.1111/imj.13813. No abstract available.

PMID:
29898275
14.

Cardiovascular risk and use of conicity index in patients submitted to autologous hematopoietic stem cell transplantation.

Morais SR, Viana ACC, Daltro AFCS, Mendonça PDS.

Einstein (Sao Paulo). 2018 Jun 7;16(2):eAO4253. doi: 10.1590/S1679-45082018AO4253. English, Portuguese.

15.

Malignancy associated hemophagocytic lymphohistiocytosis in children.

Singh A, Dawman L, Seth R.

J Cancer Res Ther. 2018 Apr-Jun;14(3):559-562. doi: 10.4103/0973-1482.188437.

16.

[Primary hodgkin lymphoma of thyroid: case report].

Hadri H, Fares S, Moutiqui T, Lembarki G, Moussali N, Benna NE, Regragui M, Bennani N, Naoumi S, Karkouri M, Quessar A.

Pan Afr Med J. 2017 Nov 24;28:266. doi: 10.11604/pamj.2017.28.266.13736. eCollection 2017. French.

17.

Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD.

Albano D, Patti C, Matranga D, Lagalla R, Midiri M, Galia M.

Eur J Radiol. 2018 Jun;103:90-98. doi: 10.1016/j.ejrad.2018.04.014. Epub 2018 Apr 17.

PMID:
29803392
18.

Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors.

Carella AM, Corradini P, Mussetti A, Ricardi U, Vitolo U, Viviani S.

Ann Hematol. 2018 Aug;97(8):1301-1315. doi: 10.1007/s00277-018-3366-x. Epub 2018 May 25. Review.

PMID:
29802458
19.

Imitating the Great Imitator The Intersection of Sarcoidosis and Hodgkin's Lymphoma A Report of Two Cases.

Outlaw D, Mehta A, Dalvi SR.

Bull Hosp Jt Dis (2013). 2018 Jun;76(2):143-148.

PMID:
29799375
20.

Hepatic Lymphoma Diagnosis.

Choi WT, Gill RM.

Surg Pathol Clin. 2018 Jun;11(2):389-402. doi: 10.1016/j.path.2018.02.003. Epub 2018 Mar 21. Review.

PMID:
29751882

Supplemental Content

Loading ...
Support Center